100+ Sunitinib PowerPoint (PPT) Presentations, Sunitinib PPTs

Sunitinib - PowerPoint PPT Presentation

Adjuvant and neo-adjuvant therapies for RCC

Adjuvant and neo-adjuvant therapies for RCC. Dr. Camillo Porta S.C. di Oncologia Medica I.R.C.C.S. Policlinico San Matteo , Pavia. Back to the basics : terminology. Adjuvant therapy:

★ ★ ★ ★ ★

361 views • 23 slides

Escudier B et al. J Clin Oncol 2009:27(25):4068-4075.

Phase II Study of Sunitinib Administered in a Continuous Once-Daily Dosing Regimen in Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma. Escudier B et al. J Clin Oncol 2009:27(25):4068-4075. Sunitinib: Mechanism of Action.

★ ★ ★ ★ ★

376 views • 9 slides

Suninat 50 mg |Sunitinib | Blueberry pharmacaeuticals

Suninat 50 mg is a type of targeted therapy and is a receptor protein-tyrosine kinase inhibitor.It prevents the actions of vascular endothelial growth factor (VEGF) and is an angiogenesis inhibitor @ Blueberry pharmacaeuticals

★ ★ ★ ★ ★

74 views • 7 slides

Choices and clinical trials in early kidney cancer therapy

Choices and clinical trials in early kidney cancer therapy. E2805 adjuvant sorafenib of sunitinib or placebo post surgery open at CPMC ARISER - Adjuvant Rencarex (WX-G250) intravenous monoclonal antibody available at UCSF .

★ ★ ★ ★ ★

218 views • 6 slides

View Sunitinib PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Sunitinib PowerPoint presentations. You can view or download Sunitinib presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.

'Sunitinib' diaporamas de présentation

Sunitinib - PowerPoint PPT Presentation

Adjuvant and neo-adjuvant therapies for RCC

Escudier B et al. J Clin Oncol 2009:27(25):4068-4075.

Suninat 50 mg |Sunitinib | Blueberry pharmacaeuticals

Choices and clinical trials in early kidney cancer therapy